4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-20-061714
Chief Executive Officer sold 10,000 shares at an average $151.40 ($1,513,953)
- Chief Executive Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Saxonov Serge · Chief Executive Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 1 in the form | +6,250 | $1.20 | $7,500 | 973,431 | D |
| 2020-12-01 | Exercise or conversion : show line 2 in the form | +3,750 | $5.04 | $18,900 | 977,181 | D |
| 2020-12-01 | Sale : show line 3 in the form | −3,004 | $150.01 | $450,620 | 974,177 | D |
| 2020-12-01 | Sale : show line 4 in the form | −3,398 | $151.02 | $513,174 | 970,779 | D |
| 2020-12-01 | Sale : show line 5 in the form | −1,091 | $151.92 | $165,749 | 969,688 | D |
| 2020-12-01 | Sale : show line 6 in the form | −2,174 | $153.26 | $333,179 | 967,514 | D |
| 2020-12-01 | Sale : show line 7 in the form | −333 | $153.84 | $51,230 | 967,181 | D |
| Open-market sales · 10,000 sh · avg $151.40 · $1,513,953 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −6,250 | $1.20 | 2027-10-18 | 6,250 | 109,860 | D |
| 2020-12-01 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −3,750 | $5.04 | 2028-11-02 | 3,750 | 124,515 | D |
Loading xslF345X03/doc4.xml…